[Weight reduction. Antiobesity drug treatment in type-2 diabetics].
作者信息
Verspohl Eugen J
机构信息
Institut für Pharmazeutische und Medizinische Chemie Hittorfstr. 58-62, 48149 Münster.
出版信息
Pharm Unserer Zeit. 2002;31(3):300-7. doi: 10.1002/1615-1003(200205)31:3<300::AID-PAUZ300>3.0.CO;2-C.
Abstract
摘要
相似文献
1
[Weight reduction. Antiobesity drug treatment in type-2 diabetics].
Pharm Unserer Zeit. 2002;31(3):300-7. doi: 10.1002/1615-1003(200205)31:3<300::AID-PAUZ300>3.0.CO;2-C.
2
[Pharmacotherapy for weight loss in patients with type 2 diabetes].
Ugeskr Laeger. 2007 Aug 13;169(33):2619-22.
3
[New drugs for the treatment of obesity].
Duodecim. 1999;115(20):2191, 2193-4.
4
[Pharmacotherapy of obesity].
Ugeskr Laeger. 2004 Oct 18;166(43):3814-7.
5
New antiobesity agents in type 2 diabetes: overview of clinical trials with sibutramine and orlistat.
Diabetes Metab. 2002 Dec;28(6 Pt 1):437-45.
6
Long-term pharmacotherapy for obesity.
Obes Res. 2004 Dec;12 Suppl:163S-6S. doi: 10.1038/oby.2004.283.
7
[What effect does losing weight have on hypertension?].
MMW Fortschr Med. 2003 Jul 10;145(27-28):44.
8
The new role of pharmacotherapy for weight reduction in obesity.
Int J Clin Pract. 2002 Nov;56(9):683-6.
9
Prevention and management of obesity: pharmacology .
Proc Nutr Soc. 2000 Aug;59(3):413.
10
Pharmacologic therapies for obesity.
Gastroenterol Clin North Am. 2010 Mar;39(1):69-79. doi: 10.1016/j.gtc.2010.01.001.
Zotero 插件